BioVersys Announces First Patient Dosed in Phase 2b Clinical Trial of AlpE in Pulmonary Tuberculosis
Under the BioVersys and GSK collaboration agreement, AlpE clinical development advances with first patient dosed in Phase 2b trial within UNITE4TB, following completion of a Phase ...
Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the ...
When the COVID-19 pandemic was at its peak, and multiple variants were threatening lives around the world, scientists relied on a process called "tiled amplicon sequencing" to track the virus's spread ...
In Johnson County, Iowa, the number of tuberculosis cases has increased in recent years—and so has the cost of containing it.
Warning of rising cases in London TB hotspot where 44 in every 100,000 residents have infection - Tuberculosis remains one of the top ten causes of death worldwide ...
Researchers in Australia have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes ...
As Malaysians flock to Ramadan bazaars and breaking fast gatherings, the health ministry is reminding the public to observe tuberculosis (TB) precautions, especially in crowded and enclosed spaces. In ...
To support drug discovery, a new study has revealed fundamental features of the transcription cycle in the bacteria that causes tuberculosis.
Startup AI Diagnostics showcased its tuberculosis monitor at MWC 2026, which could one day scan for other lung- and heart-related diseases.
Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results